Establishment Labs Holdings Current Ratio 2017-2025 | ESTA
Establishment Labs Holdings current ratio from 2017 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Establishment Labs Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.24B | $0.07B | 3.33 |
| 2025-06-30 | $0.23B | $0.08B | 2.84 |
| 2025-03-31 | $0.23B | $0.07B | 3.36 |
| 2024-12-31 | $0.24B | $0.07B | 3.56 |
| 2024-09-30 | $0.18B | $0.05B | 3.62 |
| 2024-06-30 | $0.19B | $0.04B | 4.44 |
| 2024-03-31 | $0.20B | $0.05B | 4.24 |
| 2023-12-31 | $0.18B | $0.06B | 3.06 |
| 2023-09-30 | $0.19B | $0.05B | 3.71 |
| 2023-06-30 | $0.21B | $0.04B | 4.83 |
| 2023-03-31 | $0.14B | $0.04B | 3.43 |
| 2022-12-31 | $0.15B | $0.04B | 3.85 |
| 2022-09-30 | $0.14B | $0.03B | 4.27 |
| 2022-06-30 | $0.16B | $0.04B | 4.50 |
| 2022-03-31 | $0.11B | $0.04B | 3.01 |
| 2021-12-31 | $0.11B | $0.03B | 3.55 |
| 2021-09-30 | $0.13B | $0.03B | 4.10 |
| 2021-06-30 | $0.13B | $0.03B | 4.70 |
| 2021-03-31 | $0.13B | $0.03B | 5.17 |
| 2020-12-31 | $0.13B | $0.03B | 5.11 |
| 2020-09-30 | $0.13B | $0.02B | 6.65 |
| 2020-06-30 | $0.14B | $0.02B | 6.64 |
| 2020-03-31 | $0.15B | $0.02B | 6.59 |
| 2019-12-31 | $0.10B | $0.02B | 4.12 |
| 2019-09-30 | $0.10B | $0.02B | 4.81 |
| 2019-06-30 | $0.08B | $0.02B | 3.94 |
| 2019-03-31 | $0.09B | $0.02B | 5.54 |
| 2018-12-31 | $0.10B | $0.02B | 6.05 |
| 2018-09-30 | $0.11B | $0.02B | 7.06 |
| 2018-06-30 | $0.05B | $0.02B | 2.42 |
| 2018-03-31 | $0.04B | $0.02B | 1.99 |
| 2017-12-31 | $0.04B | $0.06B | 0.69 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.01B | $0.06B | 0.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.967B | $0.166B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $170.972B | 31.39 |
| HCA Healthcare (HCA) | United States | $106.211B | 17.58 |
| CVS Health (CVS) | United States | $103.446B | 11.90 |
| Elevance Health (ELV) | United States | $82.202B | 12.06 |
| Cencora (COR) | United States | $68.237B | 22.00 |
| Natera (NTRA) | United States | $33.582B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Labcorp Holdings (LH) | United States | $22.312B | 17.01 |
| Medpace Holdings (MEDP) | United States | $17.481B | 43.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.574B | 0.00 |
| Viatris (VTRS) | United States | $15.031B | 5.60 |
| ICON (ICLR) | Ireland | $14.930B | 14.81 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.940B | 13.53 |
| Revvity (RVTY) | United States | $13.212B | 24.33 |
| CochLear (CHEOY) | Australia | $12.002B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.161B | 21.50 |
| Avantor (AVTR) | United States | $8.325B | 12.72 |
| Sonic Healthcare (SKHHY) | Australia | $7.861B | 0.00 |
| HealthEquity (HQY) | United States | $7.227B | 27.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.189B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.075B | 42.18 |
| Bausch + Lomb (BLCO) | Canada | $6.114B | 40.14 |
| PACS (PACS) | United States | $5.649B | 34.35 |
| Sotera Health (SHC) | United States | $5.392B | 26.00 |
| Alignment Healthcare (ALHC) | United States | $4.662B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.892B | 50.78 |
| Concentras Parent (CON) | United States | $2.818B | 17.59 |
| Organon (OGN) | United States | $2.493B | 2.63 |
| Progyny (PGNY) | United States | $2.194B | 43.14 |
| Surgery Partners (SGRY) | United States | $2.001B | 25.78 |
| Pediatrix Medical (MD) | United States | $1.895B | 11.32 |
| Ardent Health (ARDT) | United States | $1.223B | 3.99 |
| Teladoc Health (TDOC) | United States | $1.093B | 0.00 |
| CareDx (CDNA) | United States | $1.071B | 17.50 |
| Nutex Health (NUTX) | United States | $1.039B | 7.95 |
| Omada Health (OMDA) | United States | $0.905B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.876B | 14.33 |
| InnovAge Holding (INNV) | United States | $0.807B | 0.00 |
| Embecta (EMBC) | United States | $0.730B | 4.15 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.600B | 0.00 |
| CryoPort (CYRX) | United States | $0.550B | 0.00 |
| Enhabit (EHAB) | United States | $0.544B | 24.41 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.488B | 0.00 |
| SBC Medicals (SBC) | United States | $0.451B | 8.30 |
| Agilon Health (AGL) | United States | $0.395B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.365B | 5.87 |
| Oncology Institute (TOI) | United States | $0.332B | 0.00 |
| So-Young (SY) | China | $0.310B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.302B | 63.60 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| KindlyMD (NAKA) | United States | $0.181B | 0.00 |
| LifeMD (LFMD) | United States | $0.170B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.087B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.076B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.34 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |